CD274 and neoplasm: Most of the other β-lactam antibiotics that were used in our preliminary structure–activity-relationship studies that did not deplete tumor PDL1 also failed to reduce the U251 GBM cell viability, except for modest cefazolin activity (Figure 7E), which merits further investigation.